UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

Recombinant human tissue plasminogen activator for the treatment of established severe venocclusive disease of the liver after bone marrow transplantation

Blood, 1992-11, Vol.80 (10), p.2458-2462

1992

Link zum Volltext

Verfügbarkeit prüfen

A pilot study of continuous infusion heparin for the prevention of hepatic veno-occlusive disease after bone marrow transplantation

Bone marrow transplantation (Basingstoke), 1990-06, Vol.5 (6), p.407-411

1990

Link zum Volltext

Verfügbarkeit prüfen

Prevention of transmission of hepatitis C virus in bone marrow transplantation by treating the donor with alpha-interferon

Transplantation, 1996-11, Vol.62 (9), p.1358

1996

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of a CD5-Specific Immunotoxin for Treatment of Acute Graft-Versus-Host Disease After Allogeneic Marrow Transplantation

Blood, 1996-08, Vol.88 (3), p.824-830

1996

Link zum Volltext

Verfügbarkeit prüfen

Cholesterol embolization syndrome. Occurrence after intravenous streptokinase therapy for myocardial infarction

JAMA : the journal of the American Medical Association, 1987-10, Vol.258 (14), p.1934

1987

Link zum Volltext

Verfügbarkeit prüfen

Treatment of hepatic venocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients

Blood, 1997-03, Vol.89 (5), p.1501-1506

1997

Link zum Volltext

Verfügbarkeit prüfen

Personalized Dosing of Cyclophosphamide in theTotal Body Irradiation-Cyclophosphamide Conditioning Regimen: A Phase II Trial in Patients With Hematologic Malignancy

Clinical pharmacology and therapeutics, 2009, Vol.85 (6), p.615-622

2009

Link zum Volltext

Verfügbarkeit prüfen

Testosterone replacement therapy improves mood in hypogonadal men : A clinical research center study

The journal of clinical endocrinology and metabolism, 1996-10, Vol.81 (10), p.3578-3583

1996

Link zum Volltext

Verfügbarkeit prüfen

Diminishing the risk of nonrelapse mortality in hematopoietic stem cell transplantation: Prediction of exposure to the cyclophosphamide metabolite Carboxyethylphosphoramide mustard

Clinical pharmacology and therapeutics, 2004-09, Vol.76 (3), p.270-280

2004

Link zum Volltext

Verfügbarkeit prüfen

Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site

The Journal of pharmacology and experimental therapeutics, 1992-09, Vol.262 (3), p.947

1992

Link zum Volltext

Verfügbarkeit prüfen

Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study

JAMA : the journal of the American Medical Association, 1992-04, Vol.267 (14), p.1947

1992

Link zum Volltext

Verfügbarkeit prüfen

Mood disorders in the Medically. III: Scientific review and recommendations

Biological psychiatry (1969), 2005, Vol.58 (3), p.175-189

2005

Link zum Volltext

Verfügbarkeit prüfen

The development of hepatic granulomas following interferon-α2b therapy for chronic hepatitis C infection

European journal of gastroenterology & hepatology, 1998-04, Vol.10 (4), p.349-352

1998

Link zum Volltext

Verfügbarkeit prüfen

Persantine attenuates hemorrhagic shock-induced P-selectin expression. Discussion

The American surgeon, 2000, Vol.66 (12), p.1093-1098

2000

Link zum Volltext

Verfügbarkeit prüfen

A randomized, double‐blind, placebo‐controlled trial of ursodeoxycholic acid in primary biliary cirrhosis

Hepatology (Baltimore, Md.), 1995-09, Vol.22 (3), p.759-766

1995

Link zum Volltext

Verfügbarkeit prüfen

Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail: Once-weekly fluconazole in the treatment of onychomycosis

Journal of the American Academy of Dermatology, 1998, Vol.38 (6), p.S95-S102

1998

Link zum Volltext

Verfügbarkeit prüfen

Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail: Once-weekly fluconazole in the treatment of onychomycosis

Journal of the American Academy of Dermatology, 1998, Vol.38 (6), p.S87-S94

1998

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of three once-weekly dosages of fluconazole (150, 300, or 450 mg) in distal subungual onychomycosis of the fingernail: Once-weekly fluconazole in the treatment of onychomycosis

Journal of the American Academy of Dermatology, 1998, Vol.38 (6), p.S110-S116

1998

Link zum Volltext

Verfügbarkeit prüfen

Lovastatin and the human Lens ; results of a two year study

Optometry and vision science, 1993-11, Vol.70 (11), p.937-943

1993

Link zum Volltext

Verfügbarkeit prüfen

Experience with mycophenolate mofetil (RS61443) in renal transplantation at a single center. Discussion

Annals of surgery, 1993, Vol.217 (5), p.476-484

1993

Link zum Volltext

Verfügbarkeit prüfen

Testosterone : The crucial hormone responsible for depressing myocardial function in males after trauma-hemorrhage. Discussion

Annals of surgery, 1998, Vol.227 (6), p.790-799

1998

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular actions of human endothelim in conscious sheep

Clinical and experimental pharmacology & physiology, 1989, Vol.16 (4), p.235-238

1989

Link zum Volltext

Verfügbarkeit prüfen

Benefits of quadrupole immunosuppressive therapy in recipients of living related donor kidneys : a review of 855 operations. Discussion

Annals of surgery, 1992, Vol.215 (6), p.606-617

1992

Link zum Volltext

Verfügbarkeit prüfen

Konjac-mannan and american ginsing : Emerging alternative therapies for type 2 diabetes mellitus. Discussion

Journal of the American College of Nutrition, 2001, Vol.20 (5), p.370S-383S

2001

Link zum Volltext

Verfügbarkeit prüfen

On cardiovascular effects of topical glaucoma therapy [2(2&3):99, 1983]. Reply

Journal of toxicology. Cutaneous and ocular toxicology, 1984, Vol.3 (3), p.243-250

1984

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 26

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

ThemaPharmacology. Drug Treatments

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(22)
Tagungsberichte
(4)

Sprache

Englisch
(26)
Japanisch
(2)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Recombinant human tissue plasminogen activator for the treatment of established severe venocclusive disease of the liver after bone marrow transplantation

A pilot study of continuous infusion heparin for the prevention of hepatic veno-occlusive disease after bone marrow transplantation

Prevention of transmission of hepatitis C virus in bone marrow transplantation by treating the donor with alpha-interferon

Evaluation of a CD5-Specific Immunotoxin for Treatment of Acute Graft-Versus-Host Disease After Allogeneic Marrow Transplantation

Cholesterol embolization syndrome. Occurrence after intravenous streptokinase therapy for myocardial infarction

Treatment of hepatic venocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients

Personalized Dosing of Cyclophosphamide in theTotal Body Irradiation-Cyclophosphamide Conditioning Regimen: A Phase II Trial in Patients With Hematologic Malignancy

Testosterone replacement therapy improves mood in hypogonadal men : A clinical research center study

Diminishing the risk of nonrelapse mortality in hematopoietic stem cell transplantation: Prediction of exposure to the cyclophosphamide metabolite Carboxyethylphosphoramide mustard

Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site

Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study

Mood disorders in the Medically. III: Scientific review and recommendations

The development of hepatic granulomas following interferon-α2b therapy for chronic hepatitis C infection

Persantine attenuates hemorrhagic shock-induced P-selectin expression. Discussion

A randomized, double‐blind, placebo‐controlled trial of ursodeoxycholic acid in primary biliary cirrhosis

Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail: Once-weekly fluconazole in the treatment of onychomycosis

Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail: Once-weekly fluconazole in the treatment of onychomycosis

Pharmacokinetics of three once-weekly dosages of fluconazole (150, 300, or 450 mg) in distal subungual onychomycosis of the fingernail: Once-weekly fluconazole in the treatment of onychomycosis

Lovastatin and the human Lens ; results of a two year study

Experience with mycophenolate mofetil (RS61443) in renal transplantation at a single center. Discussion

Testosterone : The crucial hormone responsible for depressing myocardial function in males after trauma-hemorrhage. Discussion

Cardiovascular actions of human endothelim in conscious sheep

Benefits of quadrupole immunosuppressive therapy in recipients of living related donor kidneys : a review of 855 operations. Discussion

Konjac-mannan and american ginsing : Emerging alternative therapies for type 2 diabetes mellitus. Discussion

On cardiovascular effects of topical glaucoma therapy [2(2&3):99, 1983]. Reply

Aktive Filter

Suchergebnisse filtern